Thiazolyl mGluR5 antagonists and methods for their use

Details for Australian Patent Application No. 2012208981 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Wang, Bowei; Eastman, Brian W.; King, Chris; Huang, Dehua; Vernier, JeanMichel; Arruda, Jeannie M.; Zhao, Xiumin; Payne, Joseph; Cosford, Nicholas D.; Smith, Nicholas D.; Poon, Steve F.; Seiders, Thomas J.; Roppe, Jeffrey R.

Agent Spruson & Ferguson

Pub. Number AU-A-2012208981

Parent 2005336513

Filing date 27 July 2012

Wipo publication date 16 August 2012

International Classifications

C07D 417/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

9 August 2012 Complete Application Filed

16 August 2012 Application Open to Public Inspection

  Published as AU-A-2012208981

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012208982-Suppressant actuator

2012208980-Overcap and system for spraying a fluid